Zdrowie i gospodarka · 30/10/2003

FDA Classifies West Nile Virus IgM Capture Elisa Assay as Class II Device

The FDA has classified the West Nile Virus IgM Capture Elisa assay as a Class II device, requiring special controls to ensure its safety and effectiveness, following a petition submitted under the Federal Food, Drug, and Cosmetic Act.